Literature DB >> 11457878

Lymphocytes are important in early atherosclerosis.

L Song1, C Leung, C Schindler.   

Abstract

Lymphocytes represent a potentially important proinflammatory cell that localizes to atherosclerotic lesions. To determine whether they contribute to lesion development, atherosclerosis-prone (LDLR(-/-)) mice were crossed with lymphocyte-deficient (RAG1(-/-)) mice to generate double knockout progeny. After 8 weeks on a Western-type diet (WTD), lesion development was reduced by 54% in double knockout mice, as compared with matched LDLR(-/-) controls. However, these significant differences in lesion area gradually subsided as the WTD was continued for 12 and 16 weeks. Consistent with this observation, histological studies determined that lesion initiation and early progression were delayed in RAG1/LDL-R double knockout mice. Differences in lesion area did not correlate with any significant alterations in plasma lipid levels. These studies suggest that lymphocytes play an important role early in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11457878      PMCID: PMC203020          DOI: 10.1172/JCI11380

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  60 in total

1.  IL-10: An "immunologic scalpel" for atherosclerosis?

Authors:  R A Terkeltaub
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

Review 2.  Signaling and transcription in T helper development.

Authors:  K M Murphy; W Ouyang; J D Farrar; J Yang; S Ranganath; H Asnagli; M Afkarian; T L Murphy
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  A, B, C...gamma!

Authors:  A R Tall; C W Schindler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-06       Impact factor: 8.311

4.  Interleukin-10 blocks atherosclerotic events in vitro and in vivo.

Authors:  L J Pinderski Oslund; C C Hedrick; T Olvera; A Hagenbaugh; M Territo; J A Berliner; A I Fyfe
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

5.  Interferon-gamma elicits arteriosclerosis in the absence of leukocytes.

Authors:  G Tellides; D A Tereb; N C Kirkiles-Smith; R W Kim; J H Wilson; J S Schechner; M I Lorber; J S Pober
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

6.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

Authors:  M Febbraio; E A Podrez; J D Smith; D P Hajjar; S L Hazen; H F Hoff; K Sharma; R L Silverstein
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

7.  The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals.

Authors:  S Gupta; H Yan; L H Wong; S Ralph; J Krolewski; C Schindler
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

8.  Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase.

Authors:  M Ishigami; D K Swertfeger; M S Hui; N A Granholm; D Y Hui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-04       Impact factor: 8.311

Review 9.  Changing concepts of atherogenesis.

Authors:  P Libby
Journal:  J Intern Med       Date:  2000-03       Impact factor: 8.989

10.  Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.

Authors:  J D Smith; E Trogan; M Ginsberg; C Grigaux; J Tian; M Miyata
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

View more
  67 in total

1.  Splenic immunity and atherosclerosis: a glimpse into a novel paradigm?

Authors:  Joseph L Witztum
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.

Authors:  Christoph J Binder; Karsten Hartvigsen; Mi-Kyung Chang; Marina Miller; David Broide; Wulf Palinski; Linda K Curtiss; Maripat Corr; Joseph L Witztum
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 3.  Atherosclerosis as autoimmune disease.

Authors:  Petr Sima; Luca Vannucci; Vaclav Vetvicka
Journal:  Ann Transl Med       Date:  2018-04

4.  Acute moderate-intensity exercise in middle-aged men has neither an anti- nor proinflammatory effect.

Authors:  Daniella Markovitch; Rex M Tyrrell; Dylan Thompson
Journal:  J Appl Physiol (1985)       Date:  2008-05-08

Review 5.  'Hot stuff': inflammatory lymphocyte populations in acute coronary syndrome.

Authors:  Natale Daniele Brunetti
Journal:  Cell Mol Immunol       Date:  2014-11-03       Impact factor: 11.530

6.  Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice.

Authors:  Rima Elhage; Pierre Gourdy; Laurent Brouchet; Jacek Jawien; Marie-José Fouque; Catherine Fiévet; Xavier Huc; Yara Barreira; Jean Claude Couloumiers; Jean-François Arnal; Francis Bayard
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

7.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.

Authors:  Andrew C Li; Christoph J Binder; Alejandra Gutierrez; Kathleen K Brown; Christine R Plotkin; Jennifer W Pattison; Annabel F Valledor; Roger A Davis; Timothy M Willson; Joseph L Witztum; Wulf Palinski; Christopher K Glass
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 8.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

Review 9.  Innate and adaptive immunity in atherosclerosis.

Authors:  René R S Packard; Andrew H Lichtman; Peter Libby
Journal:  Semin Immunopathol       Date:  2009-05-16       Impact factor: 9.623

Review 10.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.